Gregory D Lyng1, Natalie E Sheils1, Caleb J Kennedy1, Daniel O Griffin2,3, Ethan M Berke1. 1. OptumLabs, UnitedHealth Group, Minnetonka, MN, United States of America. 2. Division of Infectious Diseases, Department of Medicine, Columbia University, New York, NY, United States of America. 3. ProHealth Care, Optum, Lake Success, NY, United States of America.
Abstract
BACKGROUND: COVID-19 test sensitivity and specificity have been widely examined and discussed, yet optimal use of these tests will depend on the goals of testing, the population or setting, and the anticipated underlying disease prevalence. We model various combinations of key variables to identify and compare a range of effective and practical surveillance strategies for schools and businesses. METHODS: We coupled a simulated data set incorporating actual community prevalence and test performance characteristics to a susceptible, infectious, removed (SIR) compartmental model, modeling the impact of base and tunable variables including test sensitivity, testing frequency, results lag, sample pooling, disease prevalence, externally-acquired infections, symptom checking, and test cost on outcomes including case reduction and false positives. FINDINGS: Increasing testing frequency was associated with a non-linear positive effect on cases averted over 100 days. While precise reductions in cumulative number of infections depended on community disease prevalence, testing every 3 days versus every 14 days (even with a lower sensitivity test) reduces the disease burden substantially. Pooling provided cost savings and made a high-frequency approach practical; one high-performing strategy, testing every 3 days, yielded per person per day costs as low as $1.32. INTERPRETATION: A range of practically viable testing strategies emerged for schools and businesses. Key characteristics of these strategies include high frequency testing with a moderate or high sensitivity test and minimal results delay. Sample pooling allowed for operational efficiency and cost savings with minimal loss of model performance.
BACKGROUND:COVID-19 test sensitivity and specificity have been widely examined and discussed, yet optimal use of these tests will depend on the goals of testing, the population or setting, and the anticipated underlying disease prevalence. We model various combinations of key variables to identify and compare a range of effective and practical surveillance strategies for schools and businesses. METHODS: We coupled a simulated data set incorporating actual community prevalence and test performance characteristics to a susceptible, infectious, removed (SIR) compartmental model, modeling the impact of base and tunable variables including test sensitivity, testing frequency, results lag, sample pooling, disease prevalence, externally-acquired infections, symptom checking, and test cost on outcomes including case reduction and false positives. FINDINGS: Increasing testing frequency was associated with a non-linear positive effect on cases averted over 100 days. While precise reductions in cumulative number of infections depended on community disease prevalence, testing every 3 days versus every 14 days (even with a lower sensitivity test) reduces the disease burden substantially. Pooling provided cost savings and made a high-frequency approach practical; one high-performing strategy, testing every 3 days, yielded per person per day costs as low as $1.32. INTERPRETATION: A range of practically viable testing strategies emerged for schools and businesses. Key characteristics of these strategies include high frequency testing with a moderate or high sensitivity test and minimal results delay. Sample pooling allowed for operational efficiency and cost savings with minimal loss of model performance.
Authors: Baha Abdalhamid; Christopher R Bilder; Emily L McCutchen; Steven H Hinrichs; Scott A Koepsell; Peter C Iwen Journal: Am J Clin Pathol Date: 2020-05-05 Impact factor: 2.493
Authors: David R M Smith; Audrey Duval; Koen B Pouwels; Didier Guillemot; Jérôme Fernandes; Bich-Tram Huynh; Laura Temime; Lulla Opatowski Journal: BMC Med Date: 2020-12-08 Impact factor: 8.775
Authors: Victor M Corman; Holger F Rabenau; Ortwin Adams; Doris Oberle; Markus B Funk; Brigitte Keller-Stanislawski; Jörg Timm; Christian Drosten; Sandra Ciesek Journal: Transfusion Date: 2020-05-27 Impact factor: 3.337
Authors: Antonio La Marca; Martina Capuzzo; Tiziana Paglia; Laura Roli; Tommaso Trenti; Scott M Nelson Journal: Reprod Biomed Online Date: 2020-06-14 Impact factor: 3.828
Authors: Shari Krishnaratne; Hannah Littlecott; Kerstin Sell; Jacob Burns; Julia E Rabe; Jan M Stratil; Tim Litwin; Clemens Kreutz; Michaela Coenen; Karin Geffert; Anna Helen Boger; Ani Movsisyan; Suzie Kratzer; Carmen Klinger; Katharina Wabnitz; Brigitte Strahwald; Ben Verboom; Eva Rehfuess; Renke L Biallas; Caroline Jung-Sievers; Stephan Voss; Lisa M Pfadenhauer Journal: Cochrane Database Syst Rev Date: 2022-01-17
Authors: Scott Sherrill-Mix; Young Hwang; Aoife M Roche; Abigail Glascock; Susan R Weiss; Yize Li; Leila Haddad; Peter Deraska; Caitlin Monahan; Andrew Kromer; Jevon Graham-Wooten; Louis J Taylor; Benjamin S Abella; Arupa Ganguly; Ronald G Collman; Gregory D Van Duyne; Frederic D Bushman Journal: Genome Biol Date: 2021-06-03 Impact factor: 13.583
Authors: Joaquín Moreno-Contreras; Marco A Espinoza; Carlos Sandoval-Jaime; Marco A Cantú-Cuevas; Daniel A Madrid-González; Héctor Barón-Olivares; Oscar D Ortiz-Orozco; Asunción V Muñoz-Rangel; Cecilia Guzmán-Rodríguez; Manuel Hernández-de la Cruz; César M Eroza-Osorio; Carlos F Arias; Susana López Journal: PLoS One Date: 2022-01-25 Impact factor: 3.240
Authors: Peter I Frazier; J Massey Cashore; Ning Duan; Shane G Henderson; Alyf Janmohamed; Brian Liu; David B Shmoys; Jiayue Wan; Yujia Zhang Journal: Proc Natl Acad Sci U S A Date: 2022-01-11 Impact factor: 11.205
Authors: Jillian Wright; Erin M Driver; Devin A Bowes; Bridger Johnston; Rolf U Halden Journal: Sci Total Environ Date: 2022-01-06 Impact factor: 10.753